Cancer treatment and survivorship statistics, 2019
Abstract The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and t...
Publications
Explore 247 academic publications
Showing 12 of
247 publications
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Atezolizumab plus nab-paclitaxel prolonged progression-free survival among patients with metastatic triple-negative breast cancer in both the intention-to-treat population and t...
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
In this international study of CAR T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma in adults, high rates of durable responses were produced with the use o...
Perception of the Visual World
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Ophthalmology H...
The 2019 WHO classification of tumours of the digestive system
Contains fulltext : 229796.pdf (Publisher’s version ) (Open Access)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic annotation data along with multi-platform molecular profiles of more than 11,000 human tumors ac...
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
The addition of atezolizumab to bevacizumab plus chemotherapy significantly improved progression-free survival and overall survival among patients with metastatic nonsquamous NS...